rituximab,Bendamustine,ibrutinib
biogen,janssen,abbvie,teva pharmaceuticals,roche,novartis
['lymsm', 'rituximab']
ibrutinib plus bendamustine and rituximab shows pfs benefit in older patients with mcl #asco2022 #lymsm #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.